Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Iavarone

Showing results (41-50 of 145) with videos related to

Pageof 15
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 8, 2019
Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV InfectionElisabetta Degasperi, Roberta D'Ambrosio, Massimo Iavarone, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 24, 2018
Multimodality treatment of hepatocellular carcinoma: How field practice complies with international recommendationsAngelo Sangiovanni, Michela Triolo, Massimo Iavarone, et al.
Cancers|March 29, 2023
Low-Baseline PD1+ Granulocytes Predict Responses to Atezolizumab-Bevacizumab in Hepatocellular CarcinomaCatia Giovannini, Fabrizia Suzzi, Francesco Tovoli, et al.
Journal of Clinical Medicine|January 11, 2022
An Unprecedented Challenge: The North Italian Gastroenterologist Response to COVID-19Gian Eugenio Tontini, Giovanni Aldinio, Nicoletta Nandi, et al.
Liver Cancer|January 14, 2021
Surveillance for Hepatocellular Carcinoma Also Improves Survival of Incidentally Detected Intrahepatic Cholangiocarcinoma Arisen in Liver CirrhosisFrancesco Tovoli, Pietro Guerra, Massimo Iavarone, et al.
Hepatology (Baltimore, Md.)|September 16, 2010
Diagnosis of hepatocellular carcinoma in cirrhosis by dynamic contrast imaging: the importance of tumor cell differentiationMassimo Iavarone, Angelo Sangiovanni, Laura Virginia Forzenigo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 6, 2021
Reshape and secure HCC managing during COVID-19 pandemic: A single centre analysis of four periods in 2020 versus 2019Massimo Iavarone, Barbara Antonelli, Anna Maria Ierardi, et al.
Journal of Hepatology|March 15, 2013
Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosisMassimo Iavarone, Fabio Piscaglia, Sara Vavassori, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 16, 2015
Transarterial chemoembolization with drug-eluting beads is effective for the maintenance of the Milan-in status in patients with a small hepatocellular carcinomaMatteo Angelo Manini, Angelo Sangiovanni, Laura Martinetti, et al.
Infection and Immunity|August 30, 2021
The Interplay between Gut Microbiota and the Immune System in Liver Transplant Recipients and Its Role in InfectionsGiuseppe Ancona, Laura Alagna, Andrea Lombardi, et al.
Pageof 15

Showing results (41-50 of 145) with videos related to

Sort By:
Pageof 15
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 8, 2019
Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV InfectionElisabetta Degasperi, Roberta D'Ambrosio, Massimo Iavarone, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 24, 2018
Multimodality treatment of hepatocellular carcinoma: How field practice complies with international recommendationsAngelo Sangiovanni, Michela Triolo, Massimo Iavarone, et al.
Cancers|March 29, 2023
Low-Baseline PD1+ Granulocytes Predict Responses to Atezolizumab-Bevacizumab in Hepatocellular CarcinomaCatia Giovannini, Fabrizia Suzzi, Francesco Tovoli, et al.
Journal of Clinical Medicine|January 11, 2022
An Unprecedented Challenge: The North Italian Gastroenterologist Response to COVID-19Gian Eugenio Tontini, Giovanni Aldinio, Nicoletta Nandi, et al.
Liver Cancer|January 14, 2021
Surveillance for Hepatocellular Carcinoma Also Improves Survival of Incidentally Detected Intrahepatic Cholangiocarcinoma Arisen in Liver CirrhosisFrancesco Tovoli, Pietro Guerra, Massimo Iavarone, et al.
Hepatology (Baltimore, Md.)|September 16, 2010
Diagnosis of hepatocellular carcinoma in cirrhosis by dynamic contrast imaging: the importance of tumor cell differentiationMassimo Iavarone, Angelo Sangiovanni, Laura Virginia Forzenigo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 6, 2021
Reshape and secure HCC managing during COVID-19 pandemic: A single centre analysis of four periods in 2020 versus 2019Massimo Iavarone, Barbara Antonelli, Anna Maria Ierardi, et al.
Journal of Hepatology|March 15, 2013
Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosisMassimo Iavarone, Fabio Piscaglia, Sara Vavassori, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 16, 2015
Transarterial chemoembolization with drug-eluting beads is effective for the maintenance of the Milan-in status in patients with a small hepatocellular carcinomaMatteo Angelo Manini, Angelo Sangiovanni, Laura Martinetti, et al.
Infection and Immunity|August 30, 2021
The Interplay between Gut Microbiota and the Immune System in Liver Transplant Recipients and Its Role in InfectionsGiuseppe Ancona, Laura Alagna, Andrea Lombardi, et al.
Pageof 15